Sponsored by:
HIV Grand Rounds from the
University of Pennsylvania School of Medicine
Academic Year 2013-2014
“Real Cases from the Perleman School of Medicine at the University of Pennsylvania:
HIV/HCV Co-Infection”
Thursday, May 1, 2014
12:00 PM – 1:00 PM (EDT)
JMB Class of 1962 Auditorium
Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics
Program
Penn Center for AIDS Research
Perelman School of Medicine at the
University of Pennsylvania
Philadelphia, Pennsylvania
David E. Kaplan, MD, MSc
Assistant Professor of Medicine
Division of Gastroenterology
Perelman School of Medicine at the
University of Pennsylvania
Philadelphia, Pennsylvania
K. Rajender Reddy, MD
Professor of Medicine
Professor of Medicine in Surgery
Director of Hepatology
Director of Viral Hepatitis Center
Perelman School of Medicine at the
University of Pennsylvania
Philadelphia, Pennsylvania
Target Audience
This program has been designed for departmental/institutional faculty, fellows, residents, medical students, nurses and community
physicians in the medical specialties of HIV, infectious disease, internal medicine, family practice, dermatology, osteo-specialists,
nephrology, hematology/oncology, psychiatry, public health, and Ob/Gyn.
Educational Objectives
After completing this activity, participants should be able to:
 Apply in clinical practice approaches for preventing HIV infection and getting newly diagnosed patients into care
 Individualize ARV therapy for the treatment –naïve and treatment-experienced patients
 Manage the aging patient with HIV infection, including issues associated with cardiovascular and bone disease
Accreditation
The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1.0 AMA PRA
Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Acknowledgement of Commercial Support*
This educational activity is supported by educational grants from Gilead Sciences Medical Affairs; Janssen Therapeutics, Division of
Janssen Products, LP; and ViiV Healthcare.
For more information, please contact
Richard Gordon
847-951-5318
rgordon@viraled.com
Check your CME online at www.penncmeonline.com
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at the Perelman School of Medicine at the University of Pennsylvania for individuals who are in a position to control the
content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial
interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this
purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in
CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice,
are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all
content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to
contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were
instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, Director of
CME and the peer reviewer Zalman Agus, MD, Associate Dean for CME, have disclosed that they have no relevant financial
relationships with any commercial interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to
the content of this educational activity:
PLANNING COMMITTEE MEMBER NAME
JOHN BARTLETT, MD
BRIAN BOYLE, MD
RICK GORDON
OLIVER FULTZ
The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of
this educational activity.
PLANNING COMMITTEE MEMBER NAME NAME OF COMMERCIAL INTEREST
Calvin J. Cohen, MD, MSc
Ian Frank, MD
RELATIONSHIP
Gilead; Bristol-Myers Squibb; Merck & Co. Advisory Boards/Research Grants
Janssen, Tobira
Advisory Board
Gilead, Janssen, AbbVie, Salix
Advisor, Honorarium
GlaxoSmithKline
Research Grant
PRESENTER NAMES
NAME OF COMMERCIAL INTEREST
Ian Frank, MD
Gilead, AbbVie
Advisor
GlaxoSmithKline
Research Grant to UPenn
Merck Investigator Studies Program, Bayer Research Grant
GlaxoSmithKline
Research Grant to UPenn
David Kaplan, MD
K. Rajender Reddy, MD
Genentech-Roche, Merck,Abbvie, BMS, Vertex
Janssen, Idenix, Novartis, Gilead
Genentech-Roche, Merck, Abbvie, BMS, Vertex
Janssen, Gilead
RELATIONSHIP
Advisory Board
Advisory Board
Research Support
Research Support
Relevant Financial Relationships: Financial relationships are those relationships in which the individual benefits by receiving a salary,
royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership
interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as
employment, management position, independent contractor (including contracted research), consulting, speaking and teaching,
membership on advisory committees or review panels, board membership, and other activities from which remuneration is received
or expected.